Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Healius Limited ( (AU:HLS) ) has shared an announcement.
Healius Limited has announced significant board changes, including the appointment of Neil Vinson as a Non-Executive Director and Kathy Ostin as the Chair of the Audit Committee. Vinson, who is currently with Tanarra Capital, brings expertise in private equity and healthcare investments but will not be an independent director due to his affiliation. Additionally, Mary Weaver has resigned as Company Secretary, with Stephen Humphries continuing in the role. These changes are expected to strengthen Healius’ governance and operational capabilities.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing services that include medical diagnostics and healthcare facility management. The company focuses on optimizing operational performance and engaging in mergers and acquisitions to enhance its market positioning.
YTD Price Performance: 4.88%
Average Trading Volume: 2,065
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €642.2M
For a thorough assessment of HLS stock, go to TipRanks’ Stock Analysis page.

